Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2011; 32(03): 125-132
DOI: 10.4103/0971-5851.92808
REVIEW ARTICLE

An overview of prevention and early detection of cervical cancers

Gauravi A Mishra
Department of Preventive Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Sharmila A Pimple
Department of Preventive Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India
,
Surendra S Shastri
Department of Preventive Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India
› Author Affiliations
› Further Information
  PDF Download Permissions and Reprints

Abstract

Cervical cancer still remains the most common cancer affecting the Indian women. India alone contributes 25.41% and 26.48% of the global burden of cervical cancer cases and mortality, respectively. Ironically, unlike most other cancers, cervical cancer can be prevented through screening by identifying and treating the precancerous lesions, any time during the course of its long natural history, thus preventing the potential progression to cervical carcinoma. Several screening methods, both traditional and newer technologies, are available to screen women for cervical precancers and cancers. No screening test is perfect and hence the choice of screening test will depend on the setting where it is to be used. Similarly, various methods are available for treatment of cervical precancers and the selection will depend on the cost, morbidity, requirement of reliable biopsy specimens, resources available, etc. The recommendations of screening for cervical cancer in the Indian scenario are discussed.

Keywords

Cervix cancer - colposcopy - early detection - precancer - prevention - screening - visual examination


Publication History

Article published online:
06 August 2021

© 2011. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917.
  • 2 Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002;52,6:342-62.
  • 3 Hoffman MS, Cavanagh D. Gynecologic Oncology Program. H. Lee Moffitt Cancer Center and Research Institute. Available form: http://www.moffitt.org/moffittapps/ccj/v2n6/article3.html [Last accessed on 2011 Feb 10].
  • 4 Dinshaw KA, Rao DN, Ganesh B. Tata Memorial Hospital Cancer Registry Annual Report, Mumbai, India; 1999. p. 52.
  • 5 Yeole BB, Jussawalla DJ, Sabnis SD, Sunny L. Survival from breast and cervical cancers in Mumbai (Bombay), India. In: Sankaranarayanan R, Black RJ, Parkin DM, editors. Cancer survival in developing countries. IARC, Scientific Publication No. 145, Lyon, France: International Agency for Research in Cancer; 1998. p. 79-90.
  • 6 Woodman CB, Collins SI, Young LS. The Natural History of Cervical HPV Infection: Unresolved Issues. Nat Rev Cancer 2007;7,1:11-22.
  • 7 de Villiers EM, Fauquet, C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology 2004;324:17-27.
  • 8 Collins S, Mazloomzadeh S, Winter H, Blomfield P, Bailey A, Young LS, et al. High incidence of cervical human papillomavirus infection in women during their first sexual relationship. BJOG 2002;109:96-8.
  • 9 Singer A, Khan AM. The Benefit of Human Papillomavirus testing in Predicting Cervical Cancer. Euro Obstet Gynaecol 2009;4,1:58-61.
  • 10 Alliance for Cervical Cancer Prevention (ACCP), "Natural History of Cervical Cancer: Even Infrequent Screening of Older Women Saves Lives," Cervcial Cancer Prevention Fact Sheet (Seattle: ACCP, 2003).
  • 11 Holowaty P, Miller AB, Rohan T, To T. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 1999;91:252-8.
  • 12 Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine 2006;24 supplement 1:S1-15.
  • 13 Kawana K, Yasugi T, Taketani Y. Human papillomavirus vaccines: Current issues and future. Indian J Med Res 2009;130:341-7.
  • 14 Almonte M, Albero G, Molano M, Carcamo C, García PJ, Pérez G. Risk factors for human papillomavirus exposure and co-factors for cervical cancer in Latin America and the Caribbean. Vaccine 2008;26,11:L16-36.
  • 15 Berrington De GA, Sweetland S, Green J. Comparison of risk factors for squamous cell and adenocarcinomas of the cervix: A meta-analysis. Br J Cancer 2004;90,9:1787-91.
  • 16 Shanta V, Krishnamurthi S, Gajalakshmi CK, Swaminathan R, Ravichandran K. Epidemiology of cancer of the cervix: Global and national perspective. J Indian Med Assoc 2000;98:49-52.
  • 17 Juneja A, Sehgal A, Mitra AB, Pandey A. A survey on risk factors associated with cervical cancer. Indian J Cancer 2003;40:15-22.
  • 18 Guidelines for Management of Cervix Cancer. Indian Council of Medical Research ICMR New Delhi 2010.
  • 19 Rationale for cervical cancer prevention. In: Alliance for cervical cancer prevention (ACCP). Planning and implementing cervical cancer prevention and control programs: A Manual for Managers. Seattle: ACCP 2004. p. 3-15.
  • 20 Sankaranarayanan R, Thara S, Sharma A, Roy C, Shastri S, Mahé C, et al. Accuracy of conventional cytology: Results from a multicentre screening study in India. J Med Screen 2004;11:77-84.
  • 21 Fielder H. Cervical Screening Wales. Liquid Based Cytology - Pilot Project. Project Report Nov 2003. Available form: http://www.cancerscreening.nhs.uk/cervical/lbc.html [Last accessed on 2011 June 10].
  • 22 Arbyn M, Bergeron C, Klinkhamer P, Martin-Hirsch P, Siebers AG, Bulten J. Liquid compared with conventional cervical cytology: A systematic review and meta-analysis. Obstet Gynecol 2008;111:167-77.
  • 23 Nuovo J, Melnikow J, Howell LP. New tests for cervical cancer screening. Am Fam Physician 2001;64,5:780-6.
  • 24 Sehgal A, Singh V, Bhambhani S, Luthra UK. Screening for cervical cancer by direct inspection. Lancet 1991;338:282.
  • 25 Nene B, Deshpande S, Jayant K, Budukh AM, Dale P, Deshpande D, et al. Early detection of cervical cancer by visual inspection: A population-based study in rural India. Int J Cancer 1996;68:770-3.
  • 26 Wesley R, Sankaranarayanan R, Mathew B, Chandralekha B, Aysha Beegum A, Amma NS, et al. Evaluation of visual inspection as a screening test for cervical cancer. Br J Cancer 1997;75:436-40.
  • 27 Visual inspection with acetic acid for cervical cancer screening: Test qualities in a primary-care setting. Lancet 1999;353:869-73.
  • 28 Sankaranarayanan R, Basu P, Wesley R, Mahe C, Keita N, Gombe Mbalwa CC, et al. Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa. Int J Cancer 2004;112:341-7.
  • 29 Belinson JL, Pretorius RG, Zhang WH, Wu LY, Qiao YL, Elson P. Cervical cancer screening by simple visual inspection after acetic acid. Obstet Gynecol 2001;98:441- 4.
  • 30 Shastri SS, Dinshaw KA, Amin G, Goswami S, Patil S, Chinoy R, et al. Concurrent evaluation of visual, cytological and HPV testing as screening methods for the early detection of cervical neoplasia in Mumbai, India. Bull World Health Organ 2005;83:186-94.
  • 31 Screening: Visual Approaches. In: Planning appropriate cervical cancer prevention programmess. 2 nd Ed. Seattle WA USA: PATH 2000. p.15-8.
  • 32 Sankaranarayanan R, Wesley R, Thara S, Dhakad N, Chandralekha B, Sebastian P, et al. Test characteristics of visual inspection with 4% acetic acid (VIA) and Lugol′s iodine (VILI) in cervical cancer screening in Kerala, India. Int J Cancer 2003;106:404-8.
  • 33 Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo-Tobar A, Levin C, Mahé C, et al. Cost-effectiveness of cervical-cancer screening in five developing countries. Alliance for Cervical Cancer Prevention Cost Working Group. N Engl J Med 2005;353:2158-68.
  • 34 Colposcopy and treatment of cervical intraepithelial neoplasia: A beginner′s manual, In: Sellors JW, Sankaranarayanan R Editiros. IARC 2003-04
  • 35 Turner MJ, Byrne BM, Flannelly G, Maguire P, Lenehan PM, Murphy JF. A clinical review of cervicography. Ir J Med Sci 1990;159;50.
  • 36 Sankaranarayanan R, Chatterji R, Shastri SS, Wesley RS, Basu P, Mahe C, et al. Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: Results from a multicenter study in India. Int J Cancer 2004;112:341-7.
  • 37 Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, et al. HPV screening for cervical cancer in rural India. N Engl J Med 2009;360:1385-94.
  • 38 Martin-Hirsch PP, Paraskevaidis E, Bryant A, Dickinson HO, Keep SL. Surgery for cervical intraepithelial neoplasia. Cochrane Database Syst Rev 2010;16,6:CD001318.
  • 39 Wright TC Jr, Cox JT, Massad LS, Carlson J, Twiggs LB, Wilkinson EJ. 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol 2003;189:295-304.
  • 40 NHS. Colposcopy and programme management: Guidelines for the NHS cervical screening programme. NHSCSP 2004.
  • 41 Management of abnormal cervical cytology and histology. Clinical management guidelines for the Obstetrician and Gynecologist. ACOG Practice Bulletin 2008;99,112:1419-44.
  • 42 Smith RA, Cokkinides V, Brooks D, Saslow D, Shah M, Brawley OW. Cancer screening in the United States, 2011: A Review of Current American Cancer Society Guidelines and Issues in Cancer Screening. CA Cancer J Clin 2011;61:8-30.